| Christopher N Johnson, | |
|
5050 N Clinton St, Fort Wayne, IN 46825-5886 | |
| (260) 484-8551 | |
| (260) 482-5060 |
| Full Name | Christopher N Johnson |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 13 Years |
| Location | 5050 N Clinton St, Fort Wayne, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427345982 | NPI | - | NPPES |
| 300001741 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 5101019375 (Michigan) | Secondary |
| 207X00000X | Orthopaedic Surgery | 02005052A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkview Regional Medical Center | Fort wayne, IN | Hospital |
| Orthopaedic Hospital At Parkview North Llc | Fort wayne, IN | Hospital |
| Parkview Whitley Hospital | Columbia city, IN | Hospital |
| Adams Memorial Hospital | Decatur, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Parkview Health System Inc | 2163336967 | 1167 |
| Orthopaedics Northeast Pc | 9234024878 | 70 |
News Archive
The Trust for America's Health (TFAH) commended the U.S. Senate Appropriations Committee for approving an historic $1.27 billion for prevention and public health for fiscal year 2011. This proposed funding would include $750 million, the second installment of the new Prevention and Public Health Fund that was created by the Patient Protection and Affordable Care Act.
Kamada has announced today positive data from its Phase II study evaluating inhaled Alpha-1 Antitrypsin (AAT) delivered via an Investigational eFlow Nebulizer System (PARI Pharma GmbH), in the treatment of cystic fibrosis. The results demonstrate the product has an excellent safety profile and shows promising signs of efficacy, as indicated by a reduction in lung inflammation.
Case Comprehensive Cancer Center researchers, a research collaboration which includes University Hospitals Seidman Cancer Center and Case Western Reserve University, who last year identified new gene mutations unique to colon cancers in African Americans, have found that tumors with these mutations are highly aggressive and more likely to recur and metastasize.
Joseph F. Finn, Jr., C.P.A., Assignee for the Benefit of Creditors of Epix Pharmaceuticals, Inc. ("Epix"), announced today that the MRI imaging intellectual properties will be auctioned on May 28, 2010. The assets of Epix were transferred to him on July 20, 2009 and he is liquidating them for the benefit of Epix creditors. He recently reached an agreement with Bayer Schering Pharma that permits the sale of the MRI imaging programs.
› Verified 7 days ago
| Entity Name | Parkview Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932130952 PECOS PAC ID: 2163336967 Enrollment ID: O20031117000288 |
News Archive
The Trust for America's Health (TFAH) commended the U.S. Senate Appropriations Committee for approving an historic $1.27 billion for prevention and public health for fiscal year 2011. This proposed funding would include $750 million, the second installment of the new Prevention and Public Health Fund that was created by the Patient Protection and Affordable Care Act.
Kamada has announced today positive data from its Phase II study evaluating inhaled Alpha-1 Antitrypsin (AAT) delivered via an Investigational eFlow Nebulizer System (PARI Pharma GmbH), in the treatment of cystic fibrosis. The results demonstrate the product has an excellent safety profile and shows promising signs of efficacy, as indicated by a reduction in lung inflammation.
Case Comprehensive Cancer Center researchers, a research collaboration which includes University Hospitals Seidman Cancer Center and Case Western Reserve University, who last year identified new gene mutations unique to colon cancers in African Americans, have found that tumors with these mutations are highly aggressive and more likely to recur and metastasize.
Joseph F. Finn, Jr., C.P.A., Assignee for the Benefit of Creditors of Epix Pharmaceuticals, Inc. ("Epix"), announced today that the MRI imaging intellectual properties will be auctioned on May 28, 2010. The assets of Epix were transferred to him on July 20, 2009 and he is liquidating them for the benefit of Epix creditors. He recently reached an agreement with Bayer Schering Pharma that permits the sale of the MRI imaging programs.
› Verified 7 days ago
| Entity Name | Orthopaedics Northeast Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740268796 PECOS PAC ID: 9234024878 Enrollment ID: O20040405001087 |
News Archive
The Trust for America's Health (TFAH) commended the U.S. Senate Appropriations Committee for approving an historic $1.27 billion for prevention and public health for fiscal year 2011. This proposed funding would include $750 million, the second installment of the new Prevention and Public Health Fund that was created by the Patient Protection and Affordable Care Act.
Kamada has announced today positive data from its Phase II study evaluating inhaled Alpha-1 Antitrypsin (AAT) delivered via an Investigational eFlow Nebulizer System (PARI Pharma GmbH), in the treatment of cystic fibrosis. The results demonstrate the product has an excellent safety profile and shows promising signs of efficacy, as indicated by a reduction in lung inflammation.
Case Comprehensive Cancer Center researchers, a research collaboration which includes University Hospitals Seidman Cancer Center and Case Western Reserve University, who last year identified new gene mutations unique to colon cancers in African Americans, have found that tumors with these mutations are highly aggressive and more likely to recur and metastasize.
Joseph F. Finn, Jr., C.P.A., Assignee for the Benefit of Creditors of Epix Pharmaceuticals, Inc. ("Epix"), announced today that the MRI imaging intellectual properties will be auctioned on May 28, 2010. The assets of Epix were transferred to him on July 20, 2009 and he is liquidating them for the benefit of Epix creditors. He recently reached an agreement with Bayer Schering Pharma that permits the sale of the MRI imaging programs.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher N Johnson, 5052 N Clinton St, Fort Wayne, IN 46825-5822 Ph: (260) 484-8551 | Christopher N Johnson, 5050 N Clinton St, Fort Wayne, IN 46825-5886 Ph: (260) 484-8551 |
News Archive
The Trust for America's Health (TFAH) commended the U.S. Senate Appropriations Committee for approving an historic $1.27 billion for prevention and public health for fiscal year 2011. This proposed funding would include $750 million, the second installment of the new Prevention and Public Health Fund that was created by the Patient Protection and Affordable Care Act.
Kamada has announced today positive data from its Phase II study evaluating inhaled Alpha-1 Antitrypsin (AAT) delivered via an Investigational eFlow Nebulizer System (PARI Pharma GmbH), in the treatment of cystic fibrosis. The results demonstrate the product has an excellent safety profile and shows promising signs of efficacy, as indicated by a reduction in lung inflammation.
Case Comprehensive Cancer Center researchers, a research collaboration which includes University Hospitals Seidman Cancer Center and Case Western Reserve University, who last year identified new gene mutations unique to colon cancers in African Americans, have found that tumors with these mutations are highly aggressive and more likely to recur and metastasize.
Joseph F. Finn, Jr., C.P.A., Assignee for the Benefit of Creditors of Epix Pharmaceuticals, Inc. ("Epix"), announced today that the MRI imaging intellectual properties will be auctioned on May 28, 2010. The assets of Epix were transferred to him on July 20, 2009 and he is liquidating them for the benefit of Epix creditors. He recently reached an agreement with Bayer Schering Pharma that permits the sale of the MRI imaging programs.
› Verified 7 days ago
Ian R Nelson, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7601 W Jefferson Blvd, Fort Wayne, IN 46804 Phone: 260-436-8686 Fax: 260-436-8585 | |
Dr. John Paul Magno Manalo, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7601 W Jefferson Blvd, Fort Wayne, IN 46804 Phone: 260-436-8686 | |
William H Couch, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5050 N Clinton Street, Fort Wayne, IN 46825 Phone: 260-484-8551 Fax: 260-484-9603 | |
Steven Robert Eddy, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7601 W Jefferson Blvd, Fort Wayne, IN 46804 Phone: 260-436-8686 Fax: 260-436-8585 | |
David A Goertzen, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5050 N Clinton St, Fort Wayne, IN 46825 Phone: 260-484-8551 Fax: 260-482-5060 | |
Joseph M Mattox, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5050 N Clinton St, Fort Wayne, IN 46825 Phone: 260-484-8551 Fax: 260-482-5060 | |
Adam D Hall, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7601 W Jefferson Blvd, Fort Wayne, IN 46804 Phone: 260-436-8686 Fax: 260-436-8585 |